The European Institute of Nutritional Medicine (E.I.Nu.M.) is a non-profit organization that aims to spread concepts and tools that benefit patients and the health system in addressing Chronic Diseases. 

According to the World Health Organization, 80% of the risk factors for chronic diseases are related to lifestyle, nutrition, and environmental factors. Recent developments in the Omics sciences, such as metabolomics, permit the assessment of the role of those epigenetic factors to the development of disease and allow physicians to deliver personalized medicine.  

Our goal is to disseminate the medical model of Precision Medicine, the approach that puts the patient at the center of healthcare. Integrating cutting-edge Systems Biology tools in the diagnosis and treatment of chronic diseases. We aim to improve health, clinical effectiveness, quality of life and longevity.
The basis of Precision Medicine is that the human body is better understood when viewed as a whole. Thus, employing Systems Biology approaches such as Metabolomics, Genome Sequencing and Telomere Analysis the physician can detect and treat the root causes that led to the disease. 

For more information:

15.11.2021Name Change Announcement

We are delighted to announce that the organization’s name has changed to European INstitUte of Molecular Medicine (EINUMM).

The new name reflects the aim and scope of our organization in line with the current research advancements on autoimmune and chronic diseases.

Autoimmune diseases are the leading cause of chronic diseases, and many patients struggle to fully control the symptoms of their disease, despite the availability of new and patient-friendly treatment options.

The difficulty in treating autoimmune diseases lies in their multifactorial nature, where the causing factors act synergistically to the onset and progression of autoimmune diseases. Therefore, in parallel with the appropriate medication, their effective treatment requires the management of the causing factors involved in the aggravation of this group of diseases.

Metabolomics provide data on the phenotype (the expression of genes under the influence of microbiome and environment) that shapes the treatment according to the patient’s characteristics regarding optimizing their medication and restoring metabolic disturbances, micronutrient deficiencies, microbiome imbalance, and inflammation management.

Overall, the European INstitUte of Molecular Medicine focuses on novel precision medicine approaches to better understand the molecular mechanisms that lead to the onset, prevention and effective treatment of autoimmune and chronic diseases.

Dr. Dimitris Tsoukalas, MD
President of European INstitUte of Molecular Medicine